← Back to Search

Adapted MBCT for Acute Coronary Syndrome

N/A

Waitlist Available

Led By Christina Luberto, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is testing whether it's possible to recruit people for a study on whether a mindfulness-based cognitive therapy (MBCT) is feasible and acceptable.

Eligible Conditions

Acute Coronary Syndrome
Cardiovascular Disease
Depression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood spot acceptability: blood spot collection comfort

Blood spot acceptability: blood spot collection ease

Blood spot feasibility: percent of blood spot samples submitted at baseline

+18 more

Secondary outcome measures

Patient Health Questionnaire-9 (PHQ-9)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Virtual MBCT InterventionExperimental Treatment1 Intervention

Participants will participate in 8 weekly virtual group sessions of MBCT. Participants will be asked to complete a brief survey following each session. Within one week before and after the intervention and 3-months post-intervention participants will be asked to complete a series of questionnaires and provide self-collected blood samples. Upon completion of the intervention participants will complete an audio-or video recorded exit interview (approximately 30-60 minutes).

Group II: Virtual Health Enhancement ControlExperimental Treatment1 Intervention

Participants will participate in 8 weekly virtual group sessions that focus on cardiac health and depression education. Participants will be asked to complete a brief survey following each session. Within one week before and after the intervention and 3-months post-intervention participants will be asked to complete a series of questionnaires and provide self-collected blood samples. Upon completion of the intervention participants will complete an audio-or video recorded exit interview (approximately 30-60 minutes).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,933 Previous Clinical Trials

13,198,431 Total Patients Enrolled

19 Trials studying Acute Coronary Syndrome

4,661 Patients Enrolled for Acute Coronary Syndrome

Christina Luberto, PhDPrincipal InvestigatorMassachusetts General Hospital

1 Previous Clinical Trials

8 Total Patients Enrolled

1 Trials studying Acute Coronary Syndrome

8 Patients Enrolled for Acute Coronary Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this particular investigation include participants above the age of 25?

"This clinical trial is recruiting patients between the ages of 35 and 80. Separately, there are 578 trials open for minors aged 18 or younger, as well as 2240 studies available to those older than 65 years old."

Answered by AI

Are there any prospective participants still eligible to join this research project?

"According to clinicaltrials.gov, the enrollment for this trial has closed as of November 9th 2022. Despite its closure, there are presently 2,970 other studies actively recruiting patients from around the world."

Answered by AI

What criteria must potential participants meet to be admitted into this clinical research effort?

"Looking for approximately 50 individuals, this clinical trial seeks patients in their mid-thirties to eightieth year of life who suffer from a cardiovascular condition."

Answered by AI

What is the core purpose of this investigation?

"The primary objective of this clinical trial, to be monitored over a 6 month period, is to evaluate the rate at which adequate blood spot samples can be collected. Secondary objectives focus on assessing decentering with the Experiences Questionnaire (EQ), Mindfulness Based Cognitive Therapy-Adherence Scale and Cognitive and Affective Mindfulness Scale- Revised (CAMS-R). Participants will score anywhere between 11 - 55 for EQ, 0 - 34 for MBTAS and 12 - 48 for CAMS-R depending on how aligned they are with mindfulness practices. Data collection intervals will take place before and after intervention as well as 3 months post treatment"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCT

Christina Luberto 2021. "MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04799899.